Could eggshell membrane be an adjuvant for recombinant Hepatitis B vaccine?: A preliminary investigation

Abstract Background Despite the invasiveness of the Hepatitis B infection, its vaccines are only formulated with FDA-approved alum-based adjuvants, which poorly elicit a lasting immune response, hence the need for a more effective adjuvant system. This study evaluated the immunogenicity and toxicity...

Full description

Bibliographic Details
Main Authors: Parker Elijah Joshua, Charity Chinyere Ilo, Uzochukwu Gospel Ukachukwu, Damian Chukwu Odimegwu, Rita Onyekachukwu Asomadu, Timothy Prince Chidike Ezeorba
Format: Article
Language:English
Published: SpringerOpen 2023-04-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
Online Access:https://doi.org/10.1186/s43094-023-00481-5